Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine

Systems and Synthetic Biology, Jun 2011

Liposomes are versatile (sub)micron-sized membrane vesicles that can be used for a variety of applications, including drug delivery and in vivo imaging but they also represent excellent models for artificial membranes or cells. Several studies have demonstrated that in vitro transcription and translation can take place inside liposomes to obtain compartmentalized production of functional proteins within the liposomes (Kita et al. in Chembiochem 9(15):2403–2410, 2008; Moritani et al.in FEBS J, 2010; Kuruma et al. in Methods Mol Biol 607:161–171, 2010; Murtas et al. in Biochem Biophys Res Commun 363(1):12–17, 2007; Sunami et al. in Anal Biochem 357(1):128–136, 2006; Ishikawa et al. in FEBS Lett 576(3):387–390, 2004; Oberholzer et al. in Biochem Biophys Res Commun 261(2):238–241, 1999). Such a minimal artificial cell-based model is ideal for synthetic biology based applications. In this study, we propose the use of liposomes as artificial microbes for vaccination. These artificial microbes can be genetically programmed to produce specific antigens at will. To show proof-of-concept for this artificial cell-based platform, a bacterial in vitro transcription and translation system together with a gene construct encoding the model antigen β-galactosidase were entrapped inside multilamellar liposomes. Vaccination studies in mice showed that such antigen-expressing immunostimulatory liposomes (AnExILs) elicited higher specific humoral immune responses against the produced antigen (β-galactosidase) than control vaccines (i.e. AnExILs without genetic input, liposomal β-galactosidase or pDNA encoding β-galactosidase). In conclusion, AnExILs present a new platform for DNA-based vaccines which combines antigen production, adjuvanticity and delivery in one system and which offer several advantages over existing vaccine formulations.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs11693-010-9066-z.pdf

Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine

Maryam Amidi 0 Markus de Raad 0 Daan J. A. Crommelin 0 Wim E. Hennink 0 Enrico Mastrobattista 0 0 M. Amidi M. de Raad D. J. A. Crommelin W. E. Hennink E. Mastrobattista (&) Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , PO Box 80082, 3508 TB Utrecht, The Netherlands Liposomes are versatile (sub)micron-sized membrane vesicles that can be used for a variety of applications, including drug delivery and in vivo imaging but they also represent excellent models for artificial membranes or cells. Several studies have demonstrated that in vitro transcription and translation can take place inside liposomes to obtain compartmentalized production of functional proteins within the liposomes (Kita et al. in Chembiochem 9(15):2403-2410, 2008; Moritani et al.in FEBS J, 2010; Kuruma et al. in Methods Mol Biol 607:161-171, 2010; Murtas et al. in Biochem Biophys Res Commun 363(1):12-17, 2007; Sunami et al. in Anal Biochem 357(1):128-136, 2006; Ishikawa et al. in FEBS Lett 576(3):387-390, 2004; Oberholzer et al. in Biochem Biophys Res Commun 261(2):238-241, 1999). Such a minimal artificial cell-based model is ideal for synthetic biology based applications. In this study, we propose the use of liposomes as artificial microbes for vaccination. These artificial microbes can be genetically programmed to produce specific antigens at will. To show proof-of-concept for this artificial cell-based platform, a bacterial in vitro transcription and translation system together with a gene construct encoding the model antigen b-galactosidase were entrapped inside multilamellar liposomes. Vaccination studies in mice showed that such antigen-expressing immunostimulatory liposomes (AnExILs) elicited higher specific humoral immune responses against the produced antigen (b-galactosidase) than control vaccines (i.e. AnExILs without genetic input, liposomal b-galactosidase or pDNA encoding b-galactosidase). - Synthetic biology is a rapidly emerging interdisciplinary research field that aims to construct new biological parts and systems with new functionalities through a process of engineering and standardization. Vaccines may also benefit from a synthetic biology-based design. With vaccination the aim is to delude the immune system with an antigenic formulation to make it believe it is dealing with a natural infection, however, without causing illness. At present, the majority of vaccines on the market consist of attenuated or inactivated pathogens. Although effective, these systems are poorly defined, suffer from batch-to-batch variation and can only be used for pathogens that can be readily cultivated in the lab at scales that permit vaccine production. Moreover, as the ratio of antigenic compounds within the pathogen is more-or-less fixed, there is poor control over the direction against which antigenic compound an immune reaction will be evoked. The bottom-up design of vaccines which consist of well-defined antigenic compounds (e.g. proteins or nucleic acids) offers better control over the evoked immune reaction, however, the design of such vaccines is often empirical and in general yields vaccines that are poorly immunogenic and rely on adjuvants in order to be effective. Moreover, most vaccine production schemes are rather time-consuming, and therefore not suitable for rapid response intervention, for example, to prevent the pandemic spread of a new influenza strain in the human population. Cell-free synthetic biology may offer new ways to design potent and genetically programmable vaccines (Jewett et al. 2008; Tsuboi et al. 2008, 2010a, b; Zichel et al. 2010; Kanter et al. 2007; Simpson 2006). It is based on the in vitro transcription and translation of single or multiple gene constructs in order to obtain a functional part or system. Applications of cell-free biology include the production of membrane proteins that are difficult to express in heterologous hosts (Henderson et al. 2007; Junge et al. 2010; Beebe et al. 2010; Nozawa et al. 2010; Reckel et al. 2010; Ishihara et al. 2005; Berrier et al. 2004), high-throughput screening of protein libraries by in vitro compartmentalization (Mastrobattista et al. 2005), generation of artificial cells by encapsulation of these complex biochemical reactions into cell-sized compartments, like liposomes (Kita et al. 2008; Sunami et al. 2006, 2010; Yamaji et al. 2009; Murtas et al. 2007; Ishikawa et al. 2004; Oberholzer et al. 1999). Recently, we have shown that protein expression in liposomes can yield microgramquantities of a model antigen (Amidi et al. 2010). In this study, we propose the use of antigen-expressing immunostimulatory liposomes (AnExILs) as artificial microbes for vaccination (Fig. 1). The potential advantages of such antigen-expressing immunostimulatory liposomes (AnExILs) over conventional vaccines are numerous: the specificity of the vaccine can be easily altered by simply changing the DNA templates without having to ch (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs11693-010-9066-z.pdf

Maryam Amidi, Markus de Raad, Daan J. A. Crommelin, Wim E. Hennink, Enrico Mastrobattista. Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine, Systems and Synthetic Biology, 2011, pp. 21-31, Volume 5, Issue 1-2, DOI: 10.1007/s11693-010-9066-z